MX20639A - Acidos aminoalquilfosfinicos substituidos con fosforo y procedimiento para su preparacion - Google Patents

Acidos aminoalquilfosfinicos substituidos con fosforo y procedimiento para su preparacion

Info

Publication number
MX20639A
MX20639A MX2063990A MX2063990A MX20639A MX 20639 A MX20639 A MX 20639A MX 2063990 A MX2063990 A MX 2063990A MX 2063990 A MX2063990 A MX 2063990A MX 20639 A MX20639 A MX 20639A
Authority
MX
Mexico
Prior art keywords
denotes
phosphorus
procedure
hydrogen
preparation
Prior art date
Application number
MX2063990A
Other languages
English (en)
Inventor
Roger Graham Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX20639A publication Critical patent/MX20639A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/36Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
MX2063990A 1989-05-13 1990-05-09 Acidos aminoalquilfosfinicos substituidos con fosforo y procedimiento para su preparacion MX20639A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898911017A GB8911017D0 (en) 1989-05-13 1989-05-13 Substituted aminoalkylphosphinic acids

Publications (1)

Publication Number Publication Date
MX20639A true MX20639A (es) 1993-12-01

Family

ID=10656689

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2063990A MX20639A (es) 1989-05-13 1990-05-09 Acidos aminoalquilfosfinicos substituidos con fosforo y procedimiento para su preparacion

Country Status (24)

Country Link
EP (1) EP0399949B1 (es)
JP (1) JP2930366B2 (es)
KR (1) KR0159501B1 (es)
AT (1) ATE121095T1 (es)
AU (1) AU629335B2 (es)
CA (1) CA2016631C (es)
DD (1) DD294265A5 (es)
DE (1) DE69018514T2 (es)
DK (1) DK0399949T3 (es)
ES (1) ES2070303T3 (es)
FI (1) FI94416C (es)
GB (1) GB8911017D0 (es)
GR (1) GR3015770T3 (es)
HR (1) HRP940178A2 (es)
HU (1) HU206885B (es)
IE (1) IE66165B1 (es)
IL (1) IL94317A (es)
MX (1) MX20639A (es)
NO (1) NO176761C (es)
NZ (1) NZ233647A (es)
PT (1) PT94014B (es)
SI (1) SI9010917B (es)
YU (1) YU91790A (es)
ZA (1) ZA903611B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0767174A1 (de) * 1991-11-21 1997-04-09 Ciba-Geigy Ag Neue Aminoalkanphosphinsäuren und ihre Salze
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
EE200100027A (et) 1998-07-15 2002-06-17 Jomaa Hassan Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
SE0102055D0 (sv) * 2001-06-08 2001-06-08 Astrazeneca Ab New Compounds
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
CA2632016A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
EP1968947A1 (en) 2005-12-23 2008-09-17 AstraZeneca AB Gaba-b receptor modulators
DE102008056228A1 (de) * 2008-11-06 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, deren Salze und Ester und ihre Verwendung
DE102008056339A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
EP2621282B1 (en) 2010-09-28 2020-04-15 The Regents of The University of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311475C1 (de) * 1983-03-29 1984-08-16 Siemens AG, 1000 Berlin und 8000 München Mikroprogramm-Steuereinrichtung
DE3312165A1 (de) * 1983-04-02 1984-10-04 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von phosphinothricin
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds

Also Published As

Publication number Publication date
GB8911017D0 (en) 1989-06-28
CA2016631C (en) 2000-08-29
SI9010917A (en) 1997-06-30
ATE121095T1 (de) 1995-04-15
ZA903611B (en) 1991-02-27
PT94014B (pt) 1996-12-31
CA2016631A1 (en) 1990-11-13
IE901716L (en) 1990-11-13
EP0399949B1 (en) 1995-04-12
KR900018124A (ko) 1990-12-20
YU91790A (sh) 1992-07-20
IE66165B1 (en) 1995-12-13
PT94014A (pt) 1991-01-08
HUT53656A (en) 1990-11-28
NO902109D0 (no) 1990-05-11
SI9010917B (sl) 1999-10-31
JP2930366B2 (ja) 1999-08-03
EP0399949A1 (en) 1990-11-28
ES2070303T3 (es) 1995-06-01
FI902368A0 (fi) 1990-05-11
IL94317A0 (en) 1991-03-10
HU903012D0 (en) 1990-09-28
DK0399949T3 (da) 1995-07-03
DE69018514D1 (de) 1995-05-18
DD294265A5 (de) 1991-09-26
NO176761C (no) 1995-05-24
AU5480990A (en) 1990-11-15
AU629335B2 (en) 1992-10-01
FI94416B (fi) 1995-05-31
GR3015770T3 (en) 1995-07-31
HRP940178A2 (en) 1996-08-31
HU206885B (en) 1993-01-28
IL94317A (en) 1997-07-13
JPH0395195A (ja) 1991-04-19
KR0159501B1 (ko) 1999-01-15
NO176761B (no) 1995-02-13
DE69018514T2 (de) 1995-09-21
FI94416C (fi) 1995-09-11
NZ233647A (en) 1992-08-26
NO902109L (no) 1990-11-14

Similar Documents

Publication Publication Date Title
MX20639A (es) Acidos aminoalquilfosfinicos substituidos con fosforo y procedimiento para su preparacion
EP0747383A3 (en) Polyamine salts of clavulanic acid
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
IE43645L (en) Phenol ethers
DE69100079D1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE127801T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
NZ303251A (en) Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
DK663688A (da) Vandoploeselige camptothecinanaloger, fremgangsmaade til fremstilling deraf samt midler indeholdende disse
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
ES8402272A1 (es) Procedimiento para la preparacion de aminoacidos ciclicos o esteres de los mismos.
AR010984A1 (es) Nuevos esteres de la pleuromutilina, y el acido 1-azabiciclo-4- carbanilcarbanico; procedimiento para su preparacion y composicionesfarmaceuticas que los contienen.
PL285752A1 (en) Method for manufacturing new indenoindols and a pharmaceutical composition
EP0288907A3 (en) Method for inhibiting loss of cognitive functions employing an ace inhibitor
NO161620C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.
DK165314C (da) Farmaceutiske praeparater i form af liposomdispersioner indeholdende acylerede phospholipider, fremgangsmaade til fremstilling deraf samt blandinger til fremstilling af liposomdispersioner
EP0315433A3 (en) 3-amino-5-methyl-1h-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics
ES2002427A6 (es) Procedimient para la preparacion de nuevos analogos de gonadoliberina
DE3381885D1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ES542006A0 (es) Un procedimiento para preparar una 3-acinometil-rifamicina
IT1229854B (it) Farmaci precursori della dopamina.
IT1229853B (it) Farmaci precursori della dopamina.
IE880226L (en) 2-(2,2-difluorocyclopropyl) alkyl esters
EP0867430A3 (en) Glutamic acid derivatives and pharmaceutical compositions for the treatment of central nervous system disorders